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Pre-mRNA splicing takes place in a large and highly dynamic
complex known as the spliceosome. Here we report the optimiza-
tion of a maltose-binding protein (MBP) affinity-purification
method to isolate functional spliceosomes for electron microscopic
analysis. Visualization of the spliceosome preparations revealed
distinct 40–60 nm particles. Immunogold-conjugated antibodies to
spliceosome components specifically label these particles, which
are eliminated by treatment with either RNase or protease. More-
over, spliceosomes assembled on two different pre-mRNAs are
indistinguishable. This first visualization of purified functional
spliceosomes assembled in vitro reveals striking structural fea-
tures, including one or more central cavities and multiple elongate
lobes.
The spliceosome, which is highly conserved from yeast tomammals, contains five small nuclear RNAs (snRNAs) and
numerous distinct proteins (1–4). Early studies led to a model in
which the spliceosome assembles on pre-mRNA by sequential
binding of U1, U2, and U456 small nuclear ribonucleoprotein
particles (snRNPs) to form the E, A, B, and C intermediate
complexes (2). However, recent studies in yeast showed that a
single penta-snRNP, containing all five snRNPs, is a functional
precursor to the spliceosome (5). In mammals, all five snRNPs
are associated with both early and late functional spliceosomes
(6). These and other data have led to the proposal that the
spliceosome may be a preformed entity that associates with the
pre-mRNA and then remains bound throughout the splicing
reaction (5, 7). This spliceosome undergoes numerous dynamic
changes that may only be detectable (as the A, B, and C
complexes) when different stages of splicing are analyzed under
stringent conditions (5, 7).
Significant progress in determining the structure of the spli-
ceosome by electron microscopy was provided by analyses of
purified snRNPs, including U1, U2, U4U6, U5, and the U4
U5U6 tri-snRNP (4). These studies revealed that U1 snRNP
possesses an almost circular main body (8 nm in diameter) with
two adjacent protuberances (4–7 nm) (8, 9), U2 snRNP appears
dumbbell shaped (12–22 nm) (10, 11), and U4U5U6 tri-
snRNP has a triangle-like structure (20–25 nm) (12). Additional
progress toward understanding the structure of the spliceosome
has come from studies of the C complex isolated under stringent
conditions (high salt and heparin treated). This complex, which
contains only U2, U5, and U6 snRNPs, has an asymmetric
structure with average dimensions of 24  27 nm (13). Finally,
‘‘native spliceosomes,’’ which may correspond to mammalian
penta-snRNPs or to spliceosomes assembled on endogenous
pre-mRNAs present in splicing extracts, have been visualized by
electron microscopy (14). These complexes, isolated by gel
filtration under nonstringent conditions, are relatively homog-
enous in size (40–60 nm) with a morphology characterized by
multiple globular subunits (14).
To date, functional spliceosomes assembled in vitro have not
been visualized by electron microscopy (EM) because it has not
been possible to purify them free in solution. In this study, we
have optimized a method for obtaining highly purified functional
spliceosomes for visualization by EM. Our analysis revealed
40–60 nm particles with striking similarity to the native endog-
enous spliceosomes previously described (14).
Methods and Materials
Plasmids encoding AdML pre-mRNA or Ftz pre-mRNA have been
described (6). A fragment containing three MS2 hairpins was





The double-stranded DNA products were subcloned into the
pCR2.1 plasmid (Invitrogen), confirmed by sequencing, and
further inserted into the 3 end of AdML pre-mRNA or Ftz
pre-mRNA. The MS2-MBP (maltose-binding protein) con-
struct was a gift from M. Moore (Brandeis University,
Waltham, MA). The MS2-MBP fusion protein was expressed
in E. coli, and isolated by binding to amylose beads according
to the manufacturer (NEB, Beverly, MA), and further purified
over a Heparin Hi-trap column by using a NaCl gradient
(Pharmacia; ref. 13). The fusion proteins and pre-mRNAs
were incubated in a buffer containing 20 mM Hepes, pH 7.9,
and 60 mM NaCl, on ice for 30 min, and the binding was
assayed on a 1.5% native agarose gel. Spliceosomes were
assembled on the MS2-MBPpre-mRNA-M3 complex by using
standard conditions and isolated by gel filtration (15, 16).
Subsequently, the spliceosomes were affinity-selected on amy-
lose beads by rotating for 4 h at 4°C and were eluted with 12
mM maltose, 20 mM Hepes, pH 7.9, 60 mM NaCl, 10 mM
-mercaptoethanol, and 1 mM PMSF. For identification of
snRNAs, total RNA was prepared from equivalent amounts of
each purified complex and end-labeled with [32P]pCp
and RNA ligase. The spliceosome samples were prepared for
EM by fixation with 0.6% glutaraldehyde for 5 min at room
temperature, chromatography through 2-ml columns of
BiogelA5m (Bio-Rad), and mounting onto thin carbon foils in
a solution containing spermidine followed by rotary shadow-
casting with tungsten (14). For immunogold labeling, the
spliceosomes bound to the amylose resin were incubated with
purified primary antibodies (anti U5–40kD or trimethyl cap)
followed by goat-anti-rabbit 6-nm gold conjugate or goat-anti-
mouse 10-nm gold conjugate (Aurion), respectively, at 4°C for
2 h. The spliceosomes were then eluted after extensive washing
as described above and mounted for EM. Micrographs were
taken on a Philips CM12 instrument and images on sheet film
scanned with a Nikon LS4500 film scanner and arranged using
PHOTOSHOP software (Adobe Systems, Mountain View, CA).
Results and Discussion
Optimization of MBP-Affinity Purification for EM Analysis. To carry
out EM analysis of functional spliceosomes assembled in vitro, it was
first necessary to establish conditions for obtaining the complexes
Abbreviations: EM, electron microscopy; MBP, maltose-binding protein; snRNA, small
nuclear RNA; snRNP, small nuclear ribonucleoprotein particle.
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free in solution, highly purified, and concentrated. We recently
established an affinity purification strategy for isolating functional
spliceosomes (refs. 6 and 17; Fig. 1). In this method, the pre-mRNA
contains bacteriophage R17MS2 coat protein binding sites (hair-
pins; refs. 18–20) at the 3 end of exon 2 (ref. 21; Fig. 1a). A fusion
protein of the MS2 coat protein and MBP is bound to the hairpins
(Fig. 1b). This pre-mRNAMS2-MBP complex is then assembled
into spliceosomes by incubation in HeLa cell nuclear extract under
splicing conditions (Fig. 1c). Spliceosomes are partially purified by
Sephacryl S-500 gel filtration (Fig. 1d) and then affinity selected by
binding to Amylose beads (Fig. 1e). After washing, the spliceosomes
are eluted with maltose (Fig. 1f).
To optimize the affinity purification strategy, we first asked
whether the number of hairpins affects the efficiency of
splicing and the spliceosome purification. As demonstrated in
Fig. 2a, the presence of one, two, or three hairpins at the 3 end
of AdML exon 2 does not significantly affect splicing. The
spliceosome purification efficiency using these pre-mRNAs is
typically 10, 18, and 35%, respectively. Increasing the number
of hairpins to five or nine adversely affects the resolution of the
spliceosome on the gel filtration column (data not shown).
Thus, we chose three hairpins for further optimization (the
sequence of the cassette containing the three hairpins is shown
in Fig. 2b).
In initial EM studies, we found that the MS2-MBP protein
alone forms multimeric complexes that coelute with spliceo-
somes by gel filtration and are present in the maltose elution
(data not shown). Other tags that were tested for spliceosome
purification resulted in either high background (protein A tag)
or low binding efficiency of the spliceosome (GST or Histidine
tag). Recently, it was reported that a combination of purifying
MS2-MBP by heparin column chromatography and mutation
in the MS2 coat protein (V75Q and A81G) prevents MS2
oligomerization (13, 22). Thus, we tested this new preparation
of MS2-MBP (see Fig. 2c for protein schematic) in our studies.
To determine the minimal amount of MS2-MBP that binds
quantitatively to AdML-M3 pre-mRNA, we titrated the pro-
tein and analyzed complex formation by using a gel shift assay.
The MS2-MBP protein is specific for the hairpin-containing
RNAs, because no complexes are formed on AdML pre-
mRNA lacking the hairpins (Fig. 2d, lane 1). In the presence
of AdML-M3 pre-mRNA, MS2-MBP was assembled into
complexes in a dose-dependent manner (lanes 2–8). In the
range of a 50 –200-fold molar excess of MS2-MBP to
AdML-M3 pre-mRNA, quantitative binding of MS2-MBP to
Fig. 1. Strategy for MBP-affinity purification of the spliceosome. Spliceo-
somes are isolated by gel filtration followed by affinity purification (see text
for details).
Fig. 2. Optimization of MBP-affinity purification. (a) Insertion of MS2
hairpins at the 3 end of exon 2 does not affect splicing efficiency. AdML
pre-mRNA containing 0, 1, 2, or 3 hairpins are spliced in nuclear extract for 40
min, and total RNAs were analyzed on a 16% denaturing polyacrylamide gel.
(b) Sequence of the cassette containing three MS2 RNA binding sites (hair-
pins). The secondary structure and the bulged adenosine characteristic of the
hairpins are shown. The restriction enzyme sites of the corresponding DNA
sequence are indicated. (c) Schematic of MS2-MBP fusion protein. The muta-
tions that prevent MS2 oligomerization are indicated. (d) The MS2-MBP
protein specifically binds to AdML-M3 pre-mRNA in a dose-dependent man-
ner. AdML (lane 1) or AdML-M3 (lanes 2–8) pre-mRNA was incubated with
increasing amounts of MS2-MBP for 30 min. The RNA-protein complexes were
separated on a 1.5% agarose gel. (e) Binding of MS2-MBP to AdML-M3 does
not affect splicing efficiency. Increasing amounts of MS2-MBP protein were
incubated with AdML-M3 pre-mRNA for 30 min, followed by incubation under
splicing conditions in nuclear extract for 40 min. Total RNAs were analyzed on
a 16% denaturing polyacrylamide gel.
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one or more hairpins was observed (lanes 6–8). As shown in
Fig. 2e, AdML-M3 pre-mRNA splicing was not inhibited by a
200-fold molar excess of MS2-MBP. On the basis of these data,
we chose a 100-fold molar excess for spliceosome purification.
For EM studies, we isolated spliceosomes assembled on
AdML-M3 or Ftz-M3 pre-mRNAs. As negative controls, spliceo-
somes were also assembled on AdML or Ftz pre-mRNAs lacking
the hairpins. The splicing products and spliceosomal snRNPs were
detected in AdML-M3 or Ftz-M3 elution, but not in the AdML or
Ftz elution (Fig. 3). In addition, we found that spliceosomal proteins
specifically associate with the AdML-M3 and Ftz-M3 pre-mRNAs
(ref. 23 and data not shown). Refractionation of the purified
spliceosomes over a gel filtration column showed that they elute in
the same column fractions before and after affinity purification
(ref. 23 and data not shown). These data indicate that the purified
spliceosomes are intact.
EM Visualization of Spliceosomes. The highly purified spliceosomes
were then visualized by EM using rotary tungsten shadowing.
Representative fields of the AdML spliceosome preparation are
shown in Fig. 4A. Multiple particles ranging in size from 40–60
nm were observed. In contrast, these large particles are not
present in the AdML negative control purification (Fig. 4B).
Moreover, the particles are sensitive to Proteinase K (Fig. 4C) or
RNase A (Fig. 4D) treatment. The smaller particles observed in
all samples are MS2-MBP protein complexes (data not shown).
These data are consistent with the possibility that the RNP
complexes visualized by EM are spliceosomes.
To determine directly whether the particles that we visualize
correspond to spliceosomes, we carried out immunogold label-
ing. As shown in Fig. 5A, the particles are specifically labeled
with gold conjugates by using antibodies that recognize the
trimethyl cap at the 5 end of snRNPs (4). In addition, gold
conjugates were detected when antibodies to the U5 snRNP
40kD protein (24) were used (Fig. 5B) (indicated with arrows).
In contrast, no gold labeling was detected in the negative
controls in which the primary antibodies were omitted or the
primary and the secondary antibodies were mismatched (data
not shown). We conclude that the RNP particles visualized by
EM are spliceosomes.
Analysis of individual spliceosomes at higher magnification
revealed that they are highly structured particles with multiple
elongate, globular domains (Fig. 6). Another striking feature is
the presence of one or more large central cavities. Significantly,
spliceosomes assembled on AdML-M3 pre-mRNA (Figs. 4 and
Fig. 3. Analysis of snRNAs in purified spliceosomes. Spliceosomes were
purified using AdML-M3, AdML, Ftz-M3, or Ftz pre-mRNAs as substrates
(AdML or Ftz pre-mRNAs lacking hairpins were used for negative controls).
Total RNAs extracted from the nuclear extract (NE), AdML, AdML-M3, Ftz, or
Ftz-M3 elutions were 32P-end-labeled () or not labeled () and fractionated
on an 8% polyacrylamide gel. Note that the snRNAs are 3-end-labeled
differentially with RNA ligase (15).
Fig. 4. Visualization of purified functional spliceosomes by electron micros-
copy. (A) Three different fields of purified spliceosomes assembled on
AdML-M3 pre-mRNA. (B) Fields of control purification. (C) Fields of spliceo-
somes after treatment with Proteinase K. (D) Fields of spliceosomes after
treatment with RNase A. The scale bar represents 360 nm.
Fig. 5. Immunogold labeling of spliceosomes. Spliceosomes assembled on
AdML-M3 pre-mRNA were incubated with antitrimethyl cap antibody fol-
lowed by a secondary antibody conjugated with 10 nm gold (A) or with
anti-U5–40kD antibody followed by a secondary antibody conjugated with 6
nm gold (B). Arrows indicate the positions of gold labels. The 3-cm bars are
equal to 180 nm (A) and 110 nm (B), respectively.








5 and data not shown) or Ftz-M3 pre-mRNA (Fig. 6) have the
same types of morphologies. Moreover, the AdML and Ftz
spliceosomes are similar in size, averaging about 40–60 nm,
which is the same as that previously observed for the native
endogenous spliceosomes (14). Our purified spliceosomes also
appear remarkably similar in morphology to the native spliceo-
somes (14). We conclude that the spliceosomes assembled in
vitro are highly related to the native endogenous spliceosomes
that exist in nuclear extracts.
As shown in Fig. 3, our purified spliceosome preparation
consists of a mixture of unspliced pre-mRNA, splicing inter-
mediates, and products. All five snRNAs are also present in the
preparation. At present, it is not possible to distinguish
between the possibility that the different shapes and sizes of
the particles observed by EM are due to different views of a
single ‘‘holospliceosome’’ structure (see the introduction) or
whether we are visualizing a mixture of different spliceosomal
complexes (i.e., A, B, C, and spliced mRNP complexes). This
question also remains unanswered for the endogenous native
spliceosomes (14).
On the basis of the dimensions of native U1, U2, and U4U5U6
snRNPs (see the introduction), the size of our purified spliceosome
(40  60 nm) could accommodate at least one each of these
snRNPs. The central cavities present in the spliceosomes are not
observed in the individual snRNPs, and thus must form when all of
the snRNPs and other proteins associate with each other in the
spliceosome. As previously suggested, the globular domains may
correspond to individual snRNPs (14). Recent analysis of the
proteome of MBP-purified spliceosomes identified 145 distinct
proteins (23). As many as half of these may be non-snRNP proteins
(23). Thus, the large size of the purified spliceosome visualized by
EM may be explained not only by the snRNPs but also by numerous
non-snRNP proteins.
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